PCSKi_adherence_sr: Adherence to PCSK9 Inhibitors in Clinical Practice

Joseph E Blais published a dataset and R code for a systematic review and meta-analysis on adherence to PCSK9 inhibitors in real-world clinical practice. The dataset is 406.7 KB in size and was last updated on April 17, 2026. It includes Excel files and R scripts under a CC0 1.0 license.

Use Cases

• Estimate real-world adherence prevalence to PCSK9 inhibitors based on aggregated observational studies.
• Conduct meta-analysis of adherence phases using the provided systematic review data.
• Replicate or extend the adherence analysis using the included R code.

Strengths

• Dataset is 406.7 KB, indicating a focused and manageable size for analysis.
• Includes both raw data (XLSX) and analysis code (R) for reproducibility.
• Released under a permissive CC0 1.0 public domain license.

Limitations

• Row count and column-level documentation are unknown, limiting suitability assessment.
• Description metadata is limited; actual data quality requires manual inspection after download.

Provenance

Source

Joseph E Blais via figshare

Collection Method

Systematic review and meta-analysis of observational studies.

Freshness

Last updated 2026-04-17 03:26:47; freshness should be verified.